Latest United Kingdom Startup Funding Rounds
Startup funding in United Kingdom: recent rounds, the companies behind them and their participating investors.
- Rounds
- 396 Jan 1 – Oct 12, 2026
- Disclosed funding
- $22.3B 340 disclosed amounts
- Median round
- $9.4M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| M Develops in-house sportsbook and casino platform | $35M | Series CSeries C+ | Media & gaming | United Kingdom | Investors | |
| CO Cyb3r OperationsCompany profile Provides continuous visibility into third-party cyber risk for large enterprises Provides continuous visibility into third-party cyber risk for large enterprises | £4M | Undisclosed | Cybersecurity | United Kingdom | Investors | |
| SS Uses AI and data to streamline ship chartering | £1M | Undisclosed | Enterprise software | United Kingdom | Investors | |
| AB Provider of human induced pluripotent stem cell (iPSC) technologies | $2.8M | Undisclosed | Biotech | United Kingdom | Investors | |
| V VernaCompany profile Develops software for planning, managing, and delivering nature recovery projects Develops software for planning, managing, and delivering nature recovery projects | $4M | Undisclosed | Enterprise software | United Kingdom | Investors | |
| N NucleraCompany profile Provides rapid access to functional proteins through benchtop eProtein Discovery System Provides rapid access to functional proteins through benchtop eProtein Discovery System | $12M | Series C+ | Biotech | United Kingdom | Investors | |
| P Develops AI-enabled cardiac diagnostics platform for ECG interpretation | Undisclosed | Seed | Healthtech | United Kingdom | Investors | |
| T Provides spa, bathhouse, leisure, and activity management software | $30M | Series A | Enterprise software | United Kingdom | Investors | |
| O Develops AI-based predictive genomics approach to target discovery | £2.5M | Seed | Biotech | United Kingdom | Investors | |
| b bit.bioCompany profile Creates functional, human-relevant cells and models for research, drug discovery, and development Creates functional, human-relevant cells and models for research, drug discovery, and development | $50M | Series CSeries C+ | Biotech | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1British Business Bank
CSignum, Certain Energy, Draig Therapeutics
13rounds1led - 2Innovate UK
Adaptavate, Productive Machines, Athernal Bio
13rounds0led - 3Octopus Ventures
Metris Energy, Resolutiion, Ossprey
11rounds1led - 4Entrepreneurs First
Scarlet, Open Cosmos, CloudNC
10rounds0led - 5Mercia Ventures
givestar, Productive Machines, SCI Semiconductor
10rounds2led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.